combo news - Search News

J&J's combo extends patients' lives in head-to-head study with AstraZeneca's drug

Johnson & Johnson said on Tuesday its chemotherapy-free combination treatment showed a meaningful improvement in extending lives of patients with a type of lung cancer, compared to AstraZeneca's blockbuster drug Tagrisso.

Becker's Hospital Review · 2d

Drug extends survival in lung cancer patients: J&J

The combination showed a median overall survival improvement of over one year compared to osimertinib, marking the first such survival benefit in this patient group. Overall survival, which measures the length of time patients live after starting treatment,

J&J says cancer drug combination showed survival benefit over Tagrisso

Results from the Mariposa study found a regimen of Rybrevant and Lazcluze helped patients with a common form of advanced lung cancer live longer.

FierceBiotech13h

Repare cans plans for phase 3 cancer combo trial in latest money-saving move

As recently as last month, the biotech had been setting out plans for a phase 3 trial of the combo treatment for later in ...

1d

The Unexpected Color Combo Taking 2025 by Storm, According to Designers

For 2025, 44% of the designers polled said that plum and forest green will be the ruling color combo this year. With almost ...

1don MSN

Five Guys to test new combo at select St. Louis locations

Five Guys is testing a new "Classic Combo" meal in select St. Louis region locations to celebrate their 40th anniversary, ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results